| Name | clarithromycin |
|---|---|
| Synonyms |
ClithroMycin API
Clithromycin 34 TE-031 Clithromycinum Infex 6-O-METHYLERYTHROMYCIN Clithromycin Identity (10 mg) Klacid-d3 6-(4-DIMETHYLAMINO-3-HYDROXY-6-METHYLTETRAHYDROPYRAN-2-YL-OXY)-14-ETHYL-12,13-DIHYDROXY-4-(5-HYDROXY) Clarosip Macladin-d3 Klicid-d3 MethylerythromycinA VeclaM-d3 6-Methoxyerythromycin Antibiotic TE 31 ERYTHROMYCIN,-METHYL-METHYLERYTHROMYCIN /CLITHROMYCIN BIAXIN Macladin Klacid UNII-H1250JIK0A klacid Klicid Clythromycin Abbott Naxy Clacid Clarihexal Mavid Clithromycin Identity (20 mg) (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(Dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-12,13-dihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-7-methoxy-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione (non-preferred name) Clithromycin Powder chlithromycin Clacee (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy]-14-ethyl-12,13-dihydroxy-7-methoxy-3,5,7,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3-(dimethylamino)-β-Dxylo-hexopyranosyl]oxy]oxacyclotetradecane-2,10-dione Resclar Clithromycin IMP TE 031-d3 Clithromycin-13C-D3 6-o-methyl-erythromyci (3R,4S,5S,6R,7R,9R,11R,12R,13R,14R)-6-(4-dimethylamino-3-hydroxy-6-methyl-oxan-2-yl)oxy-14-ethyl-12,13-dihydroxy-4-(5-hydroxy-4-methoxy-4,6-dimethyl-oxan-2-yl)oxy-7-methoxy-3,5,7,9,11,13-hexamethyl-1-oxacyclotetradecane-2,10-dione te-03 Kelamycin Claris 6-O-Methylerythromycin Clis Kladd clathromycin Naxy-d3 Veclam Zecl Clithromycin, Ready Made Solution Claric A-56268 6-O-Methylerythromycin, A-56268, TE-031, Biaxin Veclam:Zecl Cyllind 6-o-methylerythromycina Vikrol Closip Erythromycin, 6-O-methyl Klithran MR-d3 Clamicin 6-(4-DIMETHYLAMINO-3-HYDROXY-6-METHYL-OXAN-2-YL)OXY-14-ETHYL-12,13-DIHYDROXY-4-(5-HYDROXY-4-METHOXY-4,6-DIMETHYL-OXAN-2-YL)OXY-7-METHOXY-3,5,7,9,11,13-HEXAMETHYL-1-OXACYCLOTETRADECANE-2,10-DIONE (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(Dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-12,13-dihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-7-methoxy-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione Clithromycin (75 mg)G0D356977ug/mg(ai) Clithromycin a macrolide antibiotic and a CYP3A4 inhibitor Zeclar CLITHROMYCIN Klibac-d3 Clithromycin (75 mg) Fromilid Antibiotic A CLITHROMYCIN(SUBJECTTOPATENTFREE) |
| Description | Clarithromycin is a macrolide antibiotic and a CYP3A4 inhibitor.Target: Antibacterial; CYP3A4Clarithromycin is a macrolide antibiotic used to treat pharyngitis, tonsillitis, acute maxillary sinusitis, acute bacterial exacerbation of chronic bronchitis, pneumonia (especially atypical pneumonias associated with Chlamydophila pneumoniae), skin and skin structure infections. Clarithromycin prevents bacteria from growing by interfering with their protein synthesis. It binds to the subunit 50S of the bacterial ribosome and thus inhibits the translation of peptides. Clarithromycin has similar antimicrobial spectrum as erythromycin, but is more effective against certain Gram-negative bacteria, particularly Legionella pneumophila. Besides this bacteriostatic effect, clarithromycin also has bactericidal effect on certain strains, such as Haemophilus influenzae, Streptococcus pneumoniae and Neisseria gonorrhoeae. Clarithromycin is a CYP3A4 inhibitor. Even low doses of the cytochrome P4503A4 (CYP3A4) inhibitor clarithromycin increase the plasma concentrations and effects of repaglinide. Concomitant use of clarithromycin or other potent inhibitors of CYP3A4 with repaglinide may enhance its blood glucose-lowering effect and increase the risk of hypoglycemia [1, 2]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Boiling Point | 805.5±65.0 °C at 760 mmHg |
| Melting Point | 217-220ºC |
| Molecular Formula | C38H69NO13 |
| Molecular Weight | 747.953 |
| Flash Point | 440.9±34.3 °C |
| Exact Mass | 747.476868 |
| PSA | 182.91000 |
| LogP | 3.16 |
| Vapour Pressure | 0.0±6.5 mmHg at 25°C |
| Index of Refraction | 1.526 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| Symbol |
GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H302 |
| Precautionary Statements | P301 + P312 + P330 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
| Hazard Codes | Xi: Irritant;Xn: Harmful; |
| Risk Phrases | R22 |
| Safety Phrases | 26-36 |
| RIDADR | NONH for all modes of transport |
| RTECS | KF4997000 |
| HS Code | 29419000 |
| Precursor 8 | |
|---|---|
| DownStream 5 | |
| HS Code | 29419000 |
|---|